Wyndham Hotels & Resorts (WH) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Jul, 2025Executive summary
Achieved 4% global system growth year-over-year, with record first-half hotel openings and a 40% increase in new development contracts awarded.
Adjusted EBITDA grew 10% to $195M for Q2 2025, up 5% on a comparable basis; adjusted free cash flow was $88M for Q2.
EPS grew 11% year-over-year; adjusted diluted EPS increased 18% to $1.33, with net income up 1% to $87M.
Launched new technology initiatives and AI-driven tools to enhance guest experience and owner profitability.
Returned $109M to shareholders in Q2 via $77M in share repurchases and $32M in dividends.
Financial highlights
Q2 2025 net revenues were $397M, up 8% year-over-year; adjusted EBITDA was $195M, up 10%.
Net income for Q2 2025 was $87M; adjusted net income up 13% to $103M.
Adjusted free cash flow for Q2 was $88M; adjusted free cash flow yield reached 6%.
Adjusted EBITDA margin exceeded 83% in 2024, leading the industry.
$153M in stock repurchases and $64M in dividends paid in the first half of 2025.
Outlook and guidance
Raised 2025 net room growth outlook to 4.0%-4.6%; global RevPAR growth guidance reaffirmed at (2%)-1%.
Adjusted diluted EPS outlook increased to $4.60-$4.78; adjusted EBITDA expected at $730-$745M.
Adjusted free cash flow conversion rate projected at ~57%.
Marketing fund expected to breakeven for the full year, with anticipated underspending in Q3 and Q4.
Up to $550M available for business investments or shareholder returns in 2025.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025